Why REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Learn more about REXULTI for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer's Disease

Rexulti: Side effects, dosage, alternatives, and more

REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

What is agitation that may happen with dementia due to Alzheimer's disease?

Rexulti Commercial #2 (2023)

JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer's Disease

REXULTI® (brexpiprazole), Agitation associated with dementia due to Alzheimer's disease

FDA Advisors Endorse Rexulti for Agitation in Alzheimer's Dementia

First Treatment for Alzheimer's Agitation Approved by FDA

FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer's Disease

FDA approves supplemental new drug application for Rexulti to treat Alzheimer's agitation

REXULTI® (brexpiprazole) Patient Information Website